Dr. Weiping Wang received an ~1.5 million HKD of the Health and Medical Research Fund (HMRF) grant to support his work on Development of ultrasound-responsive polymeric nanoreactors for retinoblastoma therapy. HMRF is one of the major research funding schemes in Hong Kong and administered by the Food and Health Bureau of Hong Kong.
top of page
bottom of page
Comments